1-(sulfonyl)-
Novel compounds are continually sought after to treat and prevent diseases and disorders. The invention relates to 1-(sulfonyl)-N-phenylpyrrolidine-2-carboxamides which are useful for being biologically and pharmacologically screened, and to contribute to the exploration and identification of new lead molecules that are capable of modulating the functional activity of a biological target.
1. A compound having formula (I)
and the salts and stereoisomers thereof, wherein
R 1 is hydrogen, halo, hydroxy, nitro, cyano, carboxyl, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxyC 1-6 alkyl, C 1-6 alkylcarbonyl, amino, mono- or diC 1-6 alkylamino, azido, mercapto, polyhaloC 1-6 alkyl, polyhaloC 1-6 alkoxy, aryl, or Het;
R 2 is C 3-7 cycloalkyl optionally substituted with C 1-6 alkyl; C 1-6 alkyl optionally substituted with C 3-7 cycloalkyl or aryl; C 2-6 alkenyl optionally substituted with C 3-7 cycloalkyl or aryl; aryl; Het; or —NR 4a R 4b , wherein R 4a and R 4b are, each independently, C 1-6 alkyl, or R 4a and R 4b together with the nitrogen to which they are attached form a 5- or 6-membered saturated heterocyclic ring;
R 3 is C 1-6 alkylcarbonyl, C 1-6 alkyl substituted with aryl, C 1-6 alkoxyC 1-6 alkyl, C 3-7 cycloalkyl, or C 1-6 alkyl substituted with Het;
n is one, two, three, four or five;
each aryl as a group or part of a group is phenyl or naphthalenyl, each optionally substituted with one, two or three substituents selected from halo, hydroxy, nitro, cyano, carboxyl, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxyC 1-6 alkyl, C 1-6 alkylcarbonyl, amino, mono- or diC 1-6 alkylamino, azido, mercapto, polyhaloC 1-6 alkyl, and polyhaloC 1-6 alkoxy; and
each Het as a group or part of a group is a monocyclic ring with 5 or 6 ring atoms or a bicyclic ring structure comprising a 6 membered ring fused to a 4, 5, or 6 membered ring; each of the rings being saturated, partially unsaturated, or completely unsaturated; at least one of the rings containing 1 to 4 heteroatoms each independently selected from nitrogen, oxygen and sulphur; and any one of the rings being optionally substituted with one, two or three substituents each independently selected from the group consisting of halo, hydroxy, nitro, cyano, carboxyl, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxyC 1-6 alkyl, C 1-6 alkyl carbonyl, amino, mono- or diC 1-6 alkylamino, azido, mercapto, polyhaloC 1-6 alkyl, polyhaloC 1-6 alkoxy, and C 3-7 cycloalkyl.
2. A compound according to claim 1 , wherein
R 1 is hydrogen, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxyC 1-6 alkyl, C 1-6 alkylcarbonyl, aryl; or Het;
R 2 is C 1-6 alkyl optionally substituted with C 3-7 cycloalkyl or aryl; C 2-6 alkenyl optionally substituted with C 3-7 cycloalkyl or aryl; aryl or Het;
R 3 is C 1-6 alkylcarbonyl, C 1-6 alkyl substituted with aryl, C 1-6 alkoxyC 1-6 alkyl, C 3-7 cycloalkyl, or C 1-6 alkyl substituted with Het;
n is one, two or three;
each aryl as a group or part of a group is phenyl or naphthalenyl, each optionally substituted with one, two or three substituents selected from halo, hydroxy, nitro, cyano, carboxyl, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxyC 1-6 alkyl, C 1-6 alkylcarbonyl, amino, mono- or diC 1-6 alkylamino, azido, mercapto, polyhaloC 1-6 alkyl, and polyhaloC 1-6 alkoxy; and
each Het as a group or part of a group is a monocyclic ring with 5 or 6 ring atoms or a bicyclic ring structure comprising a 6 membered ring fused to a 4, 5, or 6 membered ring;
each of the rings being saturated, partially unsaturated, or completely unsaturated; at least one of the rings containing 1 to 4 heteroatoms each independently selected from nitrogen, oxygen and sulphur; and any one of the rings being optionally substituted with one, two or three substituents each independently selected from the group consisting of halo, hydroxy, nitro, cyano, carboxyl, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxyC 1-6 alkyl, C 1-6 alkylcarbonyl, amino, mono- or diC 1-6 alkyl amino, azido, mercapto, polyhaloC 1-6 alkyl, polyhaloC 1-6 alkoxy, and C 3-7 cycloalkyl.
3. A compound according to any one of claims 1 - 2 , wherein
R 1 is hydrogen;
R 2 is aryl or Het;
R 3 is C 1-6 alkylcarbonyl, C 1-6 alkyl substituted with aryl, C 1-6 alkoxyC 1-6 alkyl, C 3-7 cycloalkyl, or C 1-6 alkyl substituted with Het;
n is one;
each aryl as a group or part of a group is phenyl or naphthalenyl, each optionally substituted with two, three, four or five substituents selected from halo, amino, mono- or diC 1-6 alkylamino, and polyhaloC 1-6 alkyl; and
each Het as a group or part of a group is a monocyclic ring with 5 or 6 ring atoms or a bicyclic ring structure comprising a 6 membered ring fused to a 4, 5, or 6 membered ring;
each of the rings being saturated, partially unsaturated, or completely unsaturated; at least one of the rings containing 1 to 4 heteroatoms each independently selected from nitrogen, oxygen and sulphur; and any one of the rings being optionally substituted with one or two substituents each independently selected from the group consisting of halo and polyhaloC 1-6 alkyl.
4. A process for preparing a compound as claimed in claim 1 , said process comprising the steps of
a) reacting in a suitable medium a compound of formula (II) with a compound of formula (III)
and
b) further reacting in a suitable medium the product of step a) with R 3 —Y;
wherein
R 1 , R 2 , R 3 , and n have the same definition as provided in any one of claims 1 - 3 ;
LG is an halogen atom,
Y is an activating group in coupling reactions or a leaving group in substitution reactions,
wherein, in substitution reactions Y is an halogen atom;
wherein in coupling reactions Y is an activated carboxyl derivative, or an active ester, wherein the suitable medium of the reaction in step a) is a hydrous or anhydrous chlorinated solvent, anhydrous or non anhydrous polar aprotic solvent, at a temperature between 0° C. and 40° C.,
wherein the suitable medium of the reaction in step b) is in the presence of an inorganic or organic base, at a temperature between −78° C. and 60° C.,
and wherein the suitable medium is a polar aprotic solvent.